Facebook Pixel Code
image of little bot wearing glasses
Garron Family Cancer Centre

Lancet Oncology Commission

Launching in 2018, The Lancet Oncology Commission on Sustainable Paediatric Cancer Care is a joint partnership between PERCC, St. Jude Children’s Research and Hospital and the Harvard T.H. Chan School of Public Health. The Commission will undertake a comprehensive analysis to develop an investment case for funding management and control of childhood cancer. Cancer kills more than 100,000 children each year, and yet 80% of paediatric cancers are treatable with currently available interventions. Notably, the majority of these deaths occur in low-to-middle-income countries (LMIC) where children have poor access to health services. It is crucial that as countries transition to universal health care, childhood cancers are recognised as a priority for inclusion in benefits packages. Yet no reliable data are available in LMIC on current and future burden of childhood cancer; on cost of effective interventions; on current coverage levels for diagnostic, treatment, and care services; or on the cost, feasibility, or health and economic benefits of scaling-up effective coverage. There is an imperative for a comprehensive study to develop an investment framework to establish an evidence-based case for investing in effective interventions to address childhood cancer.
For more information, please visit: http://www.thelancet.com/campaigns/cancer/paediatric-cancer

The First Commissioner’s Meeting took place in Memphis June 17-18, pictured below.